Medicare payments influenced by postoperative complications, cost of index hospitalization in cancer patients.
Ramucirumab Plus Pemetrexed and Platinum Chemotherapy Shows Clinical Activity in Advanced Nonsquamous NSCLC
Ramucirumab demonstrated clinical activity with pemetrexed in patients with nonsquamous non-small cell lung cancer (NSCLC).
Olaparib was safe but not effective for the treatment of patients with advanced Ewing sarcoma.
Androgen Deprivation Therapy in Men with Prostate Cancer and Increased Risk of Cardiovascular Events
Association between androgen deprivation therapy and cardiovascular mortality in patients with prostate cancer.
Grading system includes independent prognostic significance of BMI, percent weight loss for patients with cancer.
Although the range of therapies for metastatic renal cell carcinoma (mRCC) is growing, managing the disease is still a challenge for clinicians.
Docetaxel can induce adverse events like febrile neutropenia in prostate cancer patients.
Docetaxel, oxaliplatin, and 5-fluorouracil (TEF) may be effective for the treatment of patients with advanced gastric cancer.
Imatinib was used more often than other tyrosine kinase inhibitors (TKIs) for the first-line treatment of chronic myeloid leukemia (CML).
The Oncologic Drugs Advisory Committee has voted against a recommendation for FDA approval of panobinostat for multiple myeloma.
Children and adolescents with renal cell carcinoma present with more advanced disease.
A new DNA-based cancer immunotherapy that targets melanoma has induced large immune response in animal models.
Tocilizumab Plus Standard of Care May Reduce Risk of Graft-Versus-Host-Disease After Stem-Cell Transplantation
Addition of tocilizumab to standard graft-versus-host disease (GVHD) prophylaxis following allogenic stem-cell transplantation may be effective.
People who smoke hookah had a signficiantly increased amount of benzene and leukemia risk.
Researchers have found that the safety profile of subcutaneous trastuzumab was consistent with previous data from the phase 3 HannaH study.
Health sector prices explain much of difference between U.S. and other high-spending countries.
Millions signing up for Medicaid to comply with federal health care law.
Almost 80% of doctors in the United States have switched from paper to electronic health records.
Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.
Several modifiable risk factors can cut chronic disease deaths over the next 15 years.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: Burkitt Lymphoma
- Non-Hodgkin Lymphoma (NHL) Treatment Regimens: AIDS-Related B-Cell Lymphoma
- Presenteeism May Be a Problem for Oncologists and, Ultimately, Their Patients
- Subcutaneous Trastuzumab May Be as Safe and Effective as Intravenous Formulation
- Researchers Identify Mechanism by Which NSAIDs Prevent Colon Cancer
- Cancer Surgery Cost Not Linked with Hospital Volume
- Ramucirumab Plus Pemetrexed and Platinum Chemotherapy Shows Clinical Activity in Advanced Nonsquamous NSCLC
- For Advanced Ewing Sarcoma, Olaparib Alone Not Effective
- High Rates of Overdetection of Recurrence of Prostate Cancer
- Androgen Deprivation Therapy in Men with Prostate Cancer and Increased Risk of Cardiovascular Events